Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Phase 1 Completed
168 enrolled
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.
Phase 1 Completed
33 enrolled
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Phase 1 Completed
23 enrolled 21 charts
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Phase 1 Completed
134 enrolled 37 charts
A Study of AL8326 in Healthy Subjects
Phase 1 Completed
6 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Phase 1 Completed
146 enrolled
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Phase 1 Completed
41 enrolled
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
Phase 1 Completed
26 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma
Phase 1 Completed
188 enrolled
CLOVER
Phase 1 Completed
105 enrolled
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Phase 1 Completed
60 enrolled
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
Phase 1 Completed
23 enrolled
Trial of BMS-986012 in Combination With Platinum and Etoposide
Phase 1 Completed
12 enrolled
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Phase 1 Completed
90 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Phase 1 Completed
12 enrolled 18 charts
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Phase 1 Completed
23 enrolled
Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients
Phase 1 Completed
11 enrolled
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase 1 Completed
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
132 enrolled
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Phase 1 Completed
105 enrolled
Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)
Phase 1 Completed
10 enrolled 13 charts
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
22 enrolled
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Phase 1 Completed
48 enrolled
Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours
Phase 1 Completed
92 enrolled
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
DUET-4
Phase 1 Completed
78 enrolled
DUET-2
Phase 1 Completed
150 enrolled
A Study of PLX2853 in Advanced Malignancies.
Phase 1 Completed
49 enrolled
A Study of SHR-1316 and Fluzoparib(SHR-3162) in Small Cell Lung Cancer Patients
Phase 1 Completed
23 enrolled
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
139 enrolled
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Phase 1 Completed
40 enrolled
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
Phase 1 Completed
48 enrolled
A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer
Phase 1 Completed
29 enrolled
Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
Phase 1 Completed
20 enrolled
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
Phase 1 Completed
14 enrolled
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Phase 1 Completed
22 enrolled
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Phase 1 Completed
72 enrolled
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
Phase 1 Completed
69 enrolled 17 charts
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Phase 1 Completed
14 enrolled
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers
Phase 1 Completed
196 enrolled 78 charts
Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
Phase 1 Completed
8 enrolled
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors
Phase 1 Completed
8 enrolled